wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37194640-615085D5-D55A-45C2-A4FB-CB8ED3A0CBDD
Q37194640-615085D5-D55A-45C2-A4FB-CB8ED3A0CBDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37194640-615085D5-D55A-45C2-A4FB-CB8ED3A0CBDD
Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily.
P577
Q37194640-615085D5-D55A-45C2-A4FB-CB8ED3A0CBDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37194640-615085D5-D55A-45C2-A4FB-CB8ED3A0CBDD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e90d7d1bd89b3c354f6dbeb2108f10636a399004
P577
2010-08-01T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
b79c9d22015cd211ce756c3919c03188